Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Omnicell (OMCL – Research Report) yesterday and set a price target of $30.00. Stan Berenshteyn’s rating is based on a nuanced analysis ...

Why Omnicell stock is drawing attention now Omnicell (OMCL) has recently attracted interest after a sharp move in its share price, with the stock showing gains over the past 3 months and solid ...

Since 1992, Omnicell has been committed to delivering innovative, outcomes-centric pharmacy and nursing solutions for all settings of care. As an intelligent medication management technology company, ...

If you are wondering whether Omnicell is attractively priced today, the key question is whether the current share price still ...

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most ...

Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks. I think a quarterly ...

It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" In this series, we measure how swiftly a ...

Omnicell, Inc., a small-cap medical technology solutions provider, posted its Q1 results Tuesday. Both the top and bottom-line results beat the consensus. However, thanks to some new headlines and ...